NCT02434692View on ClinicalTrials.gov

Safety and Performance Study of the ARGOS-IO (Intraocular) System in Patients With Primary Open Angle Glaucoma (POAG)

NACompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

July 9, 2014

Primary Completion Date

April 11, 2017

Study Completion Date

April 11, 2017

Conditions
Primary Open Angle Glaucoma (POAG)
Interventions
DEVICE

ARGOS-IO system

Implantation of ARGOS-IO pressure sensor after IOL placement within the cataract surgical procedure on day 0 (V01)

Trial Locations (11)

18057

Klinik und Poliklinik für Augenheilkunde der Universität Rostock, Rostock

24105

nordBLICK Augenklinik Bellevue, Kiel

39120

Universitätsaugenklinik Magdeburg, Magdeburg

40212

Internationale Innovative Ophthalmochirurgie Breyer-Kaymak-Klabe, Düsseldorf

44892

Universitäts-Augenklinik Bochum, Bochum

48683

Augen-Zentrum-Nordwest, Ahaus

52074

Augenklinik Universitätsklinikum Aachen, Aachen

66280

Knappschaftsklinikum Saar - Augenklinik, Sulzbach

72076

Universitäts-Augenklinik, Tübingen

74078

Augenklinik der SLK-Kliniken, Heilbronn

90403

Augenärztliches Augenchirurgisches Zentrum (AAZ), Nuremberg

All Listed Sponsors
lead

Implandata Ophthalmic Products GmbH

INDUSTRY

NCT02434692 - Safety and Performance Study of the ARGOS-IO (Intraocular) System in Patients With Primary Open Angle Glaucoma (POAG) | Biotech Hunter | Biotech Hunter